Editorial ArticleClinical Diagnostics
Radiotracer targets β‑Amyloid for early Alzheimer’s detection
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025
Alzheimer�s disease is a neurodegenerative condition characterized by progressive memory loss and cognitive decline. Research focuses on understanding the molecular and cellular mechanisms of the disease, as well as developing effective treatments and diagnostic tools. Browse our peer-reviewed product directory to find the best Alzheimer�s research products, compare options, check reviews, and get pricing directly from manufacturers.
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025